Medicare Enrolled

Dr. Samuel Baharestani, M.D.

Ophthalmology · Smithtown, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
260 E MIDDLE COUNTRY RD, Smithtown, NY 11787
6312658780
In practice since 2008 (18 years)
NPI: 1730355116 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Baharestani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Baharestani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Baharestani

Dr. Samuel Baharestani is an ophthalmology specialist in Smithtown, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Baharestani performed 2,874 Medicare services across 2,216 unique beneficiaries.

Between the years covered by Open Payments, Dr. Baharestani received a total of $96,189 from 27 pharmaceutical and/or device companies across 223 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Baharestani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 33% volume in NY $96,189 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,874
Medicare services
Top 33% in NY for ophthalmology
2,216
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~160 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
731 $80 $211
Eye photography
Photographic imaging of the interior structures of the eye.
634 $22 $125
Microfluid analysis of tears
A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes.
344 $22 $46
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
204 $1 $70
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
162 $109 $222
Visual field test, limited
A test that measures your side (peripheral) vision. This limited version assesses a restricted portion of your visual field.
161 $26 $158
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
116 $73 $185
Eyelid growth removal
A procedure to remove a growth from the eyelid.
113 $252 $618
Nasal tear duct probing
A procedure to examine and clear the tear ducts in the nose. It helps restore normal drainage of tears from the eye.
100 $169 $442
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
62 $104 $228
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
52 $142 $306
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
51 $54 $100
Removal of excessive skin and fat of upper eyelid 50 $889 $1,840
Removal of chronic eyelid growth
This procedure involves the surgical removal of a long-standing growth on the eyelid.
32 $114 $268
New patient eye exam, problem focused
A focused examination of the visual system performed during a new patient visit.
26 $69 $185
Eyelid drooping or paralysis tissue removal
A surgical procedure to remove tissue, muscle, and membrane to correct eyelid drooping or paralysis.
20 $692 $2,275
Extensive repair of turning-outward eyelid defect
A surgical procedure to correct an eyelid that turns outward. The repair addresses defects in the eyelid structure to restore normal function and appearance.
16 $474 $2,089
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$96,189
Total received (2018-2024)
Avg $13,741/year across 7 years
Top 2% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
223
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$92,309 (96.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,880 (4.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$45,060
2023
$44,888
2022
$413
2021
$1,933
2020
$2,572
2019
$1,045
2018
$277

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$44,527
Tarsus Pharmaceuticals, Inc.
$145
ANI Pharmaceuticals, Inc.
$107
REVANCE THERAPEUTICS, INC.
$95
Harrow Eye, LLC
$83
Alcon Vision LLC
$64
Oyster Point Pharma, Inc.
$21
TearLab Corp
$18
Top 3 companies account for 99.4% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$48,153
Amgen Inc.
$44,527
Merz North America, Inc.
$1,828
MERZ NORTH AMERICA, INC.
$351
Tarsus Pharmaceuticals, Inc.
$145
RxSight Inc
$131
ANI Pharmaceuticals, Inc.
$107
Novartis Pharmaceuticals Corporation
$107
Oyster Point Pharma, Inc.
$106
REVANCE THERAPEUTICS, INC.
$95
Shire North American Group Inc
$92
Harrow Eye, LLC
$83
Sun Pharmaceutical Industries Inc.
$83
Galderma Laboratories, L.P.
$72
Alcon Vision LLC
$64
Kala Pharmaceuticals, Inc.
$41
BIOTISSUE HOLDINGS, INC.
$32
Eyevance Pharmaceuticals LLC
$26
Sight Sciences, Inc.
$23
Dompe US, Inc.
$18
TearLab Corp
$18
Bausch & Lomb Americas Inc.
$18
AbbVie Inc.
$17
EYEVANCE PHARMACEUTICALS LLC
$16
Allergan, Inc.
$14
Bausch & Lomb, a division of Bausch Health US, LLC
$12
Allergan Inc.
$12
Top 3 companies account for 98.3% of all-time payments
Associated products mentioned in payments ›
BOTOX · BOTOX THERAPEUTIC · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · DAXXIFY · DOCTORS ALLERGY FORMULA · Flarex · INVELTYS · Oxervate · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · RXSIGHT CONTACT LENS · ScoutPro Osmolarity System · Simbrinza · TEPEZZA · TYRVAYA · TearCare SmartLid · TobraDex ST · XDEMVY · XEOMIN · XIIDRA · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for ophthalmology in NY.

Looking for an ophthalmology specialist in Smithtown?
Compare ophthalmologists in the Smithtown area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
235
Per 100K population
15.4
County median income
$128,329
Nearest hospital
ST CATHERINE OF SIENA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Baharestani is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of NY peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Baharestani experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Baharestani performed 731 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Baharestani receive payments from pharmaceutical companies?
Yes. Dr. Baharestani received a total of $96,189 from 27 companies across 223 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Baharestani's costs compare to other ophthalmologists in Smithtown?
Dr. Baharestani's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Baharestani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →